Drugs / γ-linoleic acid
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03914404 | Jan → Mar 2016 | diabetic polyneuropathy | Chonbuk National University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | γ-linoleic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03914404 ↗ |
| Known as | Evoprim soft capsule | “γ-linoleic acid (Evoprim soft capsule) twice a day and 4 capsules at a time.” NCT03914404 ↗ |